FCPM III SERVICES B.V.

NAARDEN, P7 · CIK 2013410 · 13F filing filed 2026-08-14

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

Legal entityFCPM III Services B.V. (NL)

Kindventure
Others nearbyBoston, MA, Almere Stad
FamilyFCPM III SERVICES B.V. · 3 related pages

$750.4m reported value +3.9% vs Q1 2026

11positions

99.9%in top 10

1 new 0 added 2 reduced 0 sold out vs Q1 2026

This report includes the holdings of 3 other managers that share the investment decisions:

Forbion Growth III Management B.V. – reports through this filing
Forbion Growth Management B.V. – reports through this filing
Forbion IV Management B.V. – reports through this filing

Shares in two reports are counted once in each security's totals.

Holdings, Q2 2026

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#	Security	Ticker	Shares	Value	% of portfolio	Change	Shares change
1	NEWAMSTERDAM PHARMA COMPANY ORDINARY SHARES NAMS	NAMS	8,490,353	$287.7m38.34%	38.34%	Reduced -708.5k	-708,547 -7.7%
2	MAPLIGHT THERAPEUTICS INC COM MPLT	MPLT	3,226,400	$115.6m15.41%	15.41%	Unchanged
3	DYNE THERAPEUTICS INC COM DYN	DYN	3,848,256	$85.5m11.39%	11.39%	Reduced -796.1k	-796,130 -17.1%
4	VOR BIOPHARMA INC COM NEW VOR	VOR	4,117,354	$75.8m10.10%	10.10%	Unchanged
5	DAMORA THERAPEUTICS INC COM NEW COM NEW		2,441,000	$63.5m8.46%	8.46%	Unchanged
6	REPLIMUNE GROUP INC COM REPL	REPL	2,808,368	$31.1m4.14%	4.14%	Unchanged
7	CRESCENT BIOPHARMA INC. COM CBIO	CBIO	1,677,852	$30.2m4.02%	4.02%	Unchanged
8	AURA BIOSCIENCES INC COM AURA	AURA	4,053,775	$28.8m3.84%	3.84%	New
9	ENGENE HOLDINGS INC COM COM		9,632,561	$16.7m2.22%	2.22%	Unchanged
10	BICYCLE THERAPEUTICS PLC SPONSORED ADS BCYC	BCYC	3,468,430	$14.7m1.96%	1.96%	Unchanged
11	ENGENE HOLDINGS INC W EXP 10/31/202 W EXP 10/31/202		2,878,148	$834.4k0.11%	0.11%	Unchanged